SK Capital Buys Drug Unit from Ion Beam

Private equity shop SK Capital Partners has acquired a 60% stake in the molecular imaging division of Belgian cancer treatment firm Ion Beam Applications, Reuters reported Monday. Ion Beam is expecting to gain over 100 million euros ($127.14 million) after selling the stake.

DealsNorth AmericaUSBriefs